VIAN Therapeutics
PrivateLast Round
Seed
Nov 24, 2024
Total Funding Raised
$2.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VIAN Therapeutics is a biotechnology company developing topical antiangiogenic peptide drugs for the treatment of microvascular retinal diseases such as diabetic retinopathy and age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIAN Therapeutics Comparables
Compare VIAN Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OcuTerra Therapeutics | 85% | |
| Exonate | 83% | |
| Oculis Holding | 76% | |
VIAN Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 24, 2024 | ||||
| Seed | Jun 1, 2024 | ||||
| Accelerator | Oct 26, 2023 |
VIAN Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BABEL Ventures | Seed |
| IndieBio | Seed, Accelerator |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| Social Starts | Seed |
| Sand Hill Angels | Seed |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 78% MoM.
VIAN Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VIAN Therapeutics's valuation, stock price, and market status.